1 |
Kass, R. E. and Natarajan, R. (2006). A default conjugate prior for variance components in generalized linear mixed models (Comment on article by Browne and Draper), Bayesian Analysis, 1, 535-542.
DOI
|
2 |
Lee, S.-C. and Lee, D. (2002). Bayesian analysis of multivariate threshold animal models using Gibbs sampling. Journal of the Korean Statistical Society 31, 177-198.
과학기술학회마을
|
3 |
Lunn, D. J., Best, N., Thomas, A. and Wakefield, J. (2002). Bayesian analysis of population PK/PD models: General concepts and software, Journal of Pharmacokinetics and Pharmacodynamics, 29, 271-307.
DOI
ScienceOn
|
4 |
Natarajan, R. and Kass, R. E. (2000). Reference Bayesian methods for general linear mixed models, Journal of American Statistical Association, 95, 227-237.
DOI
|
5 |
Oh, H. S., Ko, S.-G. and Oh, M.-S. (2003). A Bayesian approach to accessing population bioequivalence in a 2 2 crossover design, Journal of Applied Statistics, 30, 881-891.
DOI
ScienceOn
|
6 |
Shao, J., Chow, S. C. and Wang, H. (2002). Individual bioequivalence testing under designs, Statistics in Medicine, 21, 629-648.
DOI
ScienceOn
|
7 |
Tiao, G. C. and Tan, W. Y. (1965). Bayesian analysis of random-effects models in the analysis of variance. I. Posterior distribution of variance components, Biometrika, 52, 37-53.
DOI
|
8 |
Wang, C. S., Rutledge, J. J. and Gianola, D. (1994). Bayesian analysis of mixed linear models via Gibbs sampling with an application to litter size of Iberian pigs, Genetique, Selection, Evolution, 26, 91-115.
DOI
ScienceOn
|
9 |
Zeger, S. L. and Karim, M. R. (1991). Generalized linear models with random effects; A Gibbs sampling approach, Journal of the American Statistical Association, 86, 79-86.
DOI
|
10 |
Food and Drug Administration (1997). In Vivo Bioequivalence Studies Based on Population and Individual Bioequivalence Approached: Guidance for Industry, Center for Drug Evaluation and Research, Rockville, MD 20857.
|
11 |
Food and Drug Administration (2003). Bioavailability and Bioequivalence Studies for Orally Administered Drug Products: General Considerations, Center for Drug Evaluation and Research, Rockville, MD.
|
12 |
Gelman, A. (2006). Prior distributions for variance parameters in hierarchical models, Bayesian Analysis, 1, 515-533.
DOI
|
13 |
Hauck, W. W. and Anderson, S. (1992). Types of bioequivalence and related statistical considerations, International Journal of Clinical Pharmacology, Therarp, and Toxicology, 30, 181-187.
|
14 |
Hauschke, D., Steinijas, V. and Pigeot, I. (2007). Bioequivalence Studies in Drug Development: Methods and Applications, John Wiley & Sons, New York.
|
15 |
Jung, G.-J., Lim, N.-K. and Park, S.-G. (2010). Individual bioequivalence tests under 3 2 design, The Korean Journal of Applied Statistics, 23, 139-150.
과학기술학회마을
DOI
ScienceOn
|
16 |
Hobert, J. P. and Casella, G. (1996). The effect of improper priors on Gibbs sampling in hierarchical linear mixed models, Journal of the American Statistical Association, 91, 1461-1473.
DOI
|
17 |
Hsuan, F. C. and Reeve, R. (2003). Assessing individual bioequivalence with high-order cross-over designs: a unified procedure, Statistic in Medicine, 22, 2847-2860.
DOI
ScienceOn
|
18 |
Hylsop, T., Hsuan, F. and Holder, D. J. (2000). A small sample confidence interval approach to access individual bioequivalence, Statistic in Medicine, 19, 2885-2897.
DOI
ScienceOn
|
19 |
Anderson, S. and Hauck, W. W. (1990). Consideration of individual bioequivalence, Journal of Pharmacokinetics and Biopharmaceutic, 18, 259-273.
DOI
|
20 |
Best, N. G., Tan, K. K. C., Gilks, W. R. and Spiegelhalter, D. J. (1995). Estimation of population pharmacokinetics using the Gibbs sampler, Journal of Pharmacokinetics and Biopharmaceutics, 23, 407-435.
DOI
|
21 |
Carrasco, L. and Jover, L. (2003). Assessing individual bioequivalence using structural equation model, Statistics in Medicine, 15, 1619-1634.
|
22 |
Chow, S. C., Shao, J. and Wang, H. (2003). Statistical test for population bioequivalence, Statistica Sinica, 13, 539-554.
|
23 |
Daniels, M. D. and Kass, R. E. (1999). Nonconjugate Bayesian estimation of covariance matrices and its use in hierarchical models, Journal of the American Statistical Association, 94, 1254-1263.
DOI
|
24 |
Europian Medical Agency (2010). Guideline on the Investigation of Bioequivalence, Committee for Medicinal Products for Human Use, CPMP/EWP/QWP/1401/98 Rev. 1., London.
|